Since activation of T-cells is associated with enhanced IFNγ production, we investigated if IDO1-expression in tumor endothelial cells in response to agonistic CD40 mAb immunotherapy was related to increased infiltration of activated T-cells. This evidence concerns the gene IDO1 and neoplasm.